Stress, glucocorticoids and ageing of the immune system

Stress

Volumn 8, Issue 1, 2005, Pages 69-83

  Bauer, Moisés Evandro ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Aging; Glucocorticoids; Hypothalamo pituitary adrenal axis; Lymphocytes; Psychological stress

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; GROWTH HORMONE; PRASTERONE; PROGESTERONE; TESTOSTERONE;

AGED; AGING; CELLULAR IMMUNITY; DISEASE ASSOCIATION; DISTRESS SYNDROME; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IN VITRO STUDY; NEUROSECRETORY CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; SENESCENCE; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STEROID METABOLISM; STRESS; T LYMPHOCYTE ACTIVATION; THYMUS; VACCINATION;

AGING; ANIMALS; GLUCOCORTICOIDS; HUMANS; IMMUNE SYSTEM; STRESS;

EID: 20144368778     PISSN: 10253890     EISSN: None     Source Type: Journal    
DOI: 10.1080/10253890500100240     Document Type: Review

References (126)

1. Adcock IM, Lane SJ, Brown CR, Lee TH, Barnes PJ. 1995. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med 182:1951-1958.
2. Araneo B, Woods M, Daynes R. 1993. Reversal of the immunosenescent phenotype by dehydroepiandrosterone: Hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis 167:830-840.
3. Bauer ME, Vedhara K, Perks P, Wilcock G, Lightman S, Shanks N. 2000. Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids. J Neuroimmunol 103:84-92.
4. Bauer ME, Papadopoulos A, Poon L, Perks P, Lightman S, Checkley S, Shanks N. 2002. Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment resistant major depression. Psychiatr Res 113:1-15.
5. Bauer ME, Papadopoulos A, Poon L, Perks P, Lightman S, Checkley S, Shanks N. 2003. Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology 28:49-65.
6. Besedovsky H, Sorkin E, Felix D, Haas H. 1977. Hypothalamic changes during the immune response. Eur J Immunol 7:323-325.
7. Biondi M. 2001. Effects of stress on immune functions: an overview. In: Ader R, Feiten D, Cohen N, editors. Psychoneuroimmunonology. Vol. 2. San Diego: Academic Press. p 189-226.
8. Bronnegard M, Stierna P, Marcus C. 1996. Glucocorticoid resistant syndromes-molecular basis and clinical presentations. J Neuroendocrinol 8:405-415.
9. Butcher SK, Lord JM. 2004. Stress responses and innate immunity: Aging as a contributory factor. Ageing Cell 3:151-160.
10. Castle SC. 2000. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 31:578-585.
11. Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E, Chrousos G. 1996. The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGC-beta): Tissue levels, mechanism of action, and potential physiologic role. Mol Med 2:597-607.
12. Collaziol D, Luz C, Dornelles F, Cruz I, Bauer ME. 2004. Psychoneuroendocrine correlates of lymphocyte subsets during healthy ageing. Mech Ageing Dev 125:219-227.
13. Corpas S, Harman M, Blackmann MR. 1993. Human growth hormone and human aging. Endocr Rev 14:20-39.
14. Danenberg H, Ben-Yehuda A, Zakay-Rones Z, Friedman G. 1995. Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine 13:1445-1448.
15. Danenberg H, Ben-Yehuda A, Zakay-Rones Z, Gross D. 1997. Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects. J Clin Endocrinol Metab 82:2911-2914.
16. Daynes R, Dudley D, Araneo B. 1990. Regulation of murine lymphokine production in vivo. II Dehydroepiandrosterone is a natural enhancer of interleukin-2 synthesis by helper T cells. Eur J Immunol 20:793-802.
17. Daynes R, Araneo B, Ershler W, Maloney C, Li G-Z, Ryu S-Y 1993. Altered regulation of IL-6 production with normal aging-possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 150:5219-5230.
18. de Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. 1998. Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301.
19. Deuschle M, Gotthardt U, Schweiger U, Weber B, Korner A, Schmider J, Standhardt H, Lammers C, Heuser I. 1997. With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its amplitude flattens. Life Sci 61:2239-2246.
20. Dew MA, Reynolds CF, Frank E, Begley AE, Miller MD, Cornes C, Mazumdar S, Perel JM, Kupfer DJ. 1998. Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients. Am J Psychiatry 155:759-799.
21. Dhabhar F, McEwen B, Spencer R. 1993. Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels-a comparison between Sprague-Dawley, Fischer 344 and Lewis rats. Brain Res 16:89-98.
22. Di Santo E, Sironi M, Mennini T. 1996. A glucocorticoid receptor independent mechanism for neurosteroid inhibition of tumor necrosis factor production. Eur J Pharmacol 299:179-186.
23. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW, Jr, Taub DD. 2004. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114:57-66.
24. Englander EW, Gomez GA, Greeley GH, Jr. 2004. Alterations in stomach ghrelin production and in ghrelin-induced growth hormone secretion in the aged rat. Mech Ageing Dev 125:871-875.
25. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM. 2004. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101:17312-17315.
26. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R. 1993. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23:2375-2378.
27. Fauci A. 1975. Mechanisms of corticosteroid action on lymphocyte subpopulations. Immunology 28:669-679.
28. Ferrari E, Arcaini A, Gornati R, Pelanconi L, Cravello L, Fioravanti M, Solerte SB, Magri F. 2000. Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. Exp Gerontol 35:1239-1250.
29. Ferrari E, Cravello L, Muzzoni B, Casaritti D, Paltro M, Sorlete SB, Fioravanti M, Cuzzoni G, Pontiggia B, Magri F. 2001. Age-related changes of the hypothalamic-pituitary-adrenal axis: Phathophysiological correlates. Eur J Endocrinol 144:319-329.
30. Ferrari E, Mirani M, Barili L, Falvo F, Solerte SB, Cravello L, Pini L, Magri F. 2004. Cognitive and affective disorders in the elderly: A neuroendocrine study. Arch Gerontol Geriatr Suppl: 171-182.
31. Gabriel H, Schmitt B, Kindermann W. 1993. Age-related increase of CD45RO+ lymphocytes in physically active adults. Eur J Immunol 23:2704-2706.
32. Gabriel P, Cakman I, Rink L. 2002. Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp Gerontol 37:235-247.
33. Galon J, Franchimont D, Hiroi N, Frey G, Boetner A, Ehrart-Bornstein M, O'Shea J, Chrousos GP, Bornstein S. 2002. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16:61-71.
34. Ginaldi L, Loreto MF, Corsi MP, Modesti M, De Martinis M. 2001. Immunosenescence and infectious diseases. Microbes Infect 3:851-857.
35. Glaser R, Sheridan J, Malarkey WB, MacCallum RC, Kiecolt-Glaser JK. 2000. Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom Med 62:804-807.
36. Glaser R, McCallum R, Laskowski BF, Malarkey WB, Sheridan J, Kiecolt-Glaser J. 2001. Evidence fora shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging. J Gerontol Med Sci 56A:M477-M482.
37. Globerson A, Effros R. 2000. Ageing of lymphocytes and lymphocytes in the aged. Immunol Today 21:515-521.
38. Gold P, Goodwin F, Chrousos G. 1988. Clinical and biochemical manifestations of depression I. N Engl J Med 319:348-413.
39. Gold R, Buttgereit F, Toyka KV. 2001. Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders. J Neuroimmunol 117:1-8.
40. Grasso G, Lodi L, Lupo C, Muscettola M. 1997. Glucocorticoid receptors in human peripheral blood mononuclear cells in relation to age and to sport activity. Life Sci 61:301-308.
41. Halbreich U, Asnis G, Zumoff B, Nathan R, Shindledecke R. 1984. Effect of age and sex on cortisol secretion in depressives and normals. Psychiatr Res 13:221-229.
42. Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, DeBruyere M. 1992. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 13:215-218.
43. Harbuz M, Rees R, Lightman S. 1993. Hypothalamo-pituitary responses to acute stress and changes in circulating glucocorticoids during chronic adjuvant-induced arthritis in the rat. Am J Physiol 264:R179-R185.
44. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi N. 1994. Spontaneous growth hormone (GH) secretion by unstimulated human lymphocytes and the effects of gh-releasing hormone and somatostatin. J Clin Endocrinol Metab 79:1678-1680.
45. Hearing SD, Norman M, Smyth C, Foy C, Dayan CM. 1999. Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab 84:4149-4154.
46. Henson SM, Pido-Lopez J, Aspinall R. 2004. Reversal of thymic atrophy. Exp Gerontol 39:673-678.
47. Heuser I, Deuschle M, Luppa P, Schweiger U, Standhadt H, Weber B. 1998. Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab 83:3130-3133.
48. Howieson DB, Camicioli R, Quinn J, Silben LC, Care B, Moore MM, Dame A, Sexton G, Kaye JA. 2003. Natural history of cognitive decline in the old old. Neurology 60:1489-1494.
49. Juruena MF, Cleare AJ, Bauer ME, Pariante CM. 2003. Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders. Acta Neuropsychiatr 15:354-367.
50. Kam J, Szefler S, Surs W, Sher E, Leung D. 1993. Combination of IL-2 and IL-4 reduces glucocorticoid receptor- binding affinity and T cell response to glucocorticoids. J Immunol 151:3460-3466.
51. Kavelaars A, Cats B, Visser G, Zegers B, Bakker J, Van Rees E, Heijnen C. 1996. Ontogeny of the response of human peripheral blood T cells to glucocorticoids. Brain Behav Immun 10:288-297.
52. Kiecolt-Glaser J, Dura J, Speicher C, Trask J, Glaser R. 1991. Spousal caregivers of dementia victims: Longitudinal changes in immunity and health. Psychosom Med 53:345-362.
53. Kiecolt-Glaser J, Marucha P, Malarkey W, Mercado A, Glaser R. 1995. Slowing of wound healing by psychological stress. Lancet 346:1194-1196.
54. Kiecolt-Glaser J, Glaser R, Gravenstein S, Malarkey W, Sheridan J. 1996. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci USA 93:3043-3047.
55. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. 2003. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 100:9090-9095.
56. Kirschbaum C, Pirke KM, Hellhammer DH. 1993. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28:76-81.
57. Kirschbaum C, Prussner J, Stone A, Federenko I, Gaab J, Lintz D, Schommer N, Hellhammer D. 1995. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychol Med 57:468-474.
58. Lee AL, Ogle WO, Sapolsky RM. 2002. Stress and depression: Possible links to neuron death in the hippocampus. Bipolar Disord 4:117-128.
59. Ligthart G, Corberand J, Fournier C, Galanaud P, Humans W, Kennes B, Möller-Hermelink H, Steinmann G. 1984. Admission criteria for immunogerontological studies in man: The SENIEUR protocol. Mech Ageing Dev 28:47-55.
60. Liu J, Wang S, Liu H, Yang L, Nan G. 1997. The monitoring biomarker for immune function os lymphocytes in the elderly. Mech Ageing Dev 94:177-182.
61. Lupien S, Lecours A, Lussier I, Schwartz G, Nair N, Meaney M. 1994. Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14:2893-2903.
62. Luz C, Dornelles F, Scapini E, Collaziol D, Preissler T, Cruz I, Bauer ME. 2002. Psychological and nutritional correlates of T-cell function in the healthy elderly. Stress 5:80.
63. Luz C, Dornelles F, Preissler T, Collaziol D, Cruz I, Bauer ME. 2003. Impact of psychological and endocrine factors on cytokine production of healthy elderly people. Mech Ageing Dev 124:887-895.
64. Maeda K, Tanimoto K, Terada T, Shintani T, Kakigi T. 1991. Elevated urinary free cortisol in patients with dementia. Neurobiol Aging 12:161-163.
65. Maes M, Scharp S, Meltzer H, Bosmans E, Suy E, Calabrese J, Cosyns P. 1993. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatr Res 49:11-27.
66. Malaguarnera L, Ferlito L, Imbesi R, Gulizia G, Mauro S, Malaguarnera M, Messina A. 2000. Immunosenescence: A review. Arch Gerontol Geriatr 32:1-14.
67. Malarkey WB, Wang J, Cheney C, Glaser R, Nagaraja H. 2002. Human lymphocyte growth hormone stimulates interferon gamma production and is inhibited by cortisol and norepinephrine. J Neuroimmunol 123:180-187.
68. Martinez-Taboada V, Bartolome MJ, Amado JA, Blanco R, Garcia-Unzueta MT, Rodriguez-Valverde V, Lopez-Hoyos M. 2002. Changes in peripheral blood lymphocyte subsets in elderly subjects are associated with an impaired function of the hypothalamic-pituitary-adrenal axis. Mech Ageing Dev 123:1477-1486.
69. Mastorakos G, Chrousos GP, Weber J. 1993. Recombinant IL-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77:1690-1694.
70. Matthews JG, Ito K, Barnes PJ, Adcock IM. 2004. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol 113:1100-1108.
71. McDonald I, Lee A, Bradley A. 1981. Endocrine changes in dasyurid marsupials with differing mortality patterns. Gen Comp Endocrinol 44:292-294.
72. McEwen B. 1998. Protective and damaging effects of stress mediators. N Engl J Med 338:171-179.
73. McEwen B, Biron C, Brunson K, Bulloch K, Chambers W, Dhabhar F, Goldfarb R, Kitson R, Miller A, Spencer R, Weiss J. 1997. The role of adrenocorticosteroids as modulators of immune function in health and disease: Neural, endocrine and immune interactions. Brain Res Rev 23:79-133.
74. McEwen BS. 2003. Interacting mediators of allostasis and allostatic load: Towards an understanding of resilience in aging. Metabolism 52:10-16.
75. Migeon C, Keller A, Lawrence B, Shepard T. 1957. Dehydroepiandrosterone and androsterone levels in human plasma: Effects of age, sex, day to day diurnal variations. J Clin Endocrinol Metab 17:1051-1054.
76. Munck A, Guyre PM, Holbrook NJ. 1984. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5:25-44.
77. Murasko D, Weiner P, Kaye D. 1987. Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin Exp Immunol 70:440-448.
78. Nagata S, Golstein P. 1995. The Fas death factor. Science 267:1449-1456.
79. Nijhuis EW, Hinloopen B, van Lier RA, Nagelkerken L. 1995. Differential sensitivity of human naïve and memory CD4+ T cells for dexamethasone. Int Immunol 7:591-595.
80. Nolen-Hoeksema S, Ahrens C. 2002. Age differences and similarities in the correlates of depressive symptoms. Psychol Aging 17:116-124.
81. Oka M, Hirazawa K, Yamamoto K, Iizuka N, Hazama S, Suzuki T, Kobayashi N. 1996. Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress. Ann Surg 223:434-440.
82. Padgett DA, Loria R. 1994. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol and androstenetriol. J Immunol 153:1544-1552.
83. Pariante C, Pearce B, Pisell T, Sanshez C, Po C, Su C, Miller A. 1999a. The proinflammatory cytokine, interleukin-1α, reduces glucocorticoid receptor translocation and function. Endocrinology 140:4359-4366.
84. Pariante CM, Pearce BD, Pisell TL, Sanchez CI, Po C, Su C, Miller AH. 1999b. The proinflammatory cytokine, interleukin-1 alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 140:4359-4366.
85. Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, McLeod J, Caruso C, Franceschi C, Fulop T, Gupta S, Mariani E, Mocchegiani E, Solana R. 2002. T cells and aging. January 2002 update Front Biosci 7:d1056-d1183.
86. Pereira M, Traverse M, Barros D, Bianchini A, Martinez P. 2003. The effects of aging on leukocyte glucocorticoid receptor concentration and response to dexamethasone in dogs. Exp Gerontol 38:989-995.
87. Piani A, Brotini S, Dolso P, Budai R, Gigli GL. 2004. Sleep disturbances in elderly: a subjective evaluation over 65. Arch Gerontol Geriatr Suppl :325-331.
88. Picard D, Khursheed B, Garabedian MJ, Fortin MG, Lindquist S, Yamamoto KR. 1990. Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 348:166-168.
89. Potestio M, Pawelec G, Di Lorenzo G, Candore G, D'Anna C, Gervasi F, Lio D, Tranchida G, Caruso C, Romano GC. 1999. Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes. Exp Gerontol 34:659-673.
90. Ramirez F, Fowell D, Puklavec M, Simmonds S, Mason D 1996. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 156:2406-2412.
91. Raskind M, Peskind E, Wilkinson C. 1994. Hypothalamic-pituitary-adrenal axis regulation and human aging. Ann NY Acad Sci 746:327-335.
92. Risdon G, Moore T, Kumar V, Bennett M. 1991. Inhibition of murine natural killer cell differentiation by dehydroepiandrosterone. Blood 78:2387-2391.
93. Rivest S, Rivier C. 1994. Stress and interleukin-1 beta-induced activation of c-fos, NGFI-B and CRF gene expression in the hypothalamic PVN: Comparison between Sprague-Dawley, Fisher-344 and Lewis rats. J Neuroendocrinol 6.
94. Robertson O, Wexler B. 1957. Pituitary degeneration and adrenal tissue hyperplasia in spawning Pacific salmon. Science 125:1295-1297.
95. Rohleder N, Kudielka BM, Hellhammer DH, Wolf JM, Kirschbaum C. 2002. Age and sex steroid-related changes in glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. J Neuroimmunol 126:69-77.
96. Rohleder N, Wolf JM, Kirschbaum C. 2003. Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects. Stress 6:207-222.
97. Salehian MB, Kejriwal MK. 1999. Glucocorticoid-induced muscle atrophy: mechanisms and therapeutic strategies. Endocr Pract 5:277-281.
98. Sapolsky RM. 1998. Why zebras don't get ulcers. New York: W.H. Freeman.
99. Sapolsky RM, Krey LC, McEwen BS. 1986. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocr Rev 7:284-301.
100. Sapolsky RM, Romero LM, Munck AU. 2000. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55-89.
101. Schiepers OJ, Wichers MC, Maes M. 2005. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29:201-217.
102. Schmidt M, Lugering N, Lugering A, Pauels HG, Schulze-Osthoff K, Domschke W, Kucharzik T. 2001. Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis. J Immunol 166:1344-1351.
103. Schulz R, Beach SR. 1999. Caregiving as a risk factor for mortality: The caregiver health effects study. Jama 282:2215-2219.
104. Selye H. 1936. Syndrome produced by diverse nocuous agents. Nature 138:32.
105. Shaw WS, Patterson TL, Ziegler MG, Dimsdale JE, Semple SJ, Grant I. 1999. Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers. J Psychosom Res 46:215-227.
106. Silva C, Powell-Oliver F, Jewell C, Sar M, Allgood V, Cidlowski J. 1994. Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 59:436-442.
107. Sippell WG, Becker H, Versmold HT, Bidlingmaier F, Knorr D. 1978. Longitudinal studies of plasma aldosterone, corticosterone, deoxycorticosterone, progesterone, 17-hydroxy-progesterone, cortisol, and cortisone determined simultaneously in mother and child at birth and during the early neonatal period. I. Spontaneous delivery. J Clin Endocrinol Metab 46:971-985.
108. Spahn J, Szefler S, Surs W, Doherty D, Nimmagadda S, Leung D. 1996. A novel action of IL-13: Induction of diminished monocyte glucocorticoid receptor-binding affinity. J Immunol 157:2654-2659.
109. Starkman M, Schteingart D, Schork M. 1981. Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosom Med 43:3-18.
110. Sternberg E. 2002. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 169:429-435.
111. Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Scholmerich J, Falk W, Lang B. 1998. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: Possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 83:2012-2017.
112. Straub R, Miller L, Scholmerich J, Zietz B. 2000. Cytokines and hormones as possible links between endocrinosenescence and immunosenescence. J Neuroimmunol 109:10-15.
113. Straub RH, Cutolo M, Zietz B, Scholmerich J. 2001. The process of aging changes the interplay of the immune, endocrine and nervous systems. Mech Ageing Dev 122:1591-1611.
114. Straub R, Scholmerich J, Cutolo M. 2003. The multiple facets of premature aging in rheumatoid arthritis. Arthritis Rheum 48:2713-2721.
115. Suzuki T, Suzuki N, Daynes R, Engleman E. 1991. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 61:202-211.
116. Tamura Y, Okinaga H, Takami H. 2004. Glucocorticoid-induced osteoporosis. Biomed Pharmacother 58:500-504.
117. Trzonkowski P, Mysliwska J, Godlewska B, Szmit E, Lukaszuk K, Wieckiewicz J, Brydak L, Machala M, Landowski J, Mysliwski A. 2004. Immune consequences of the spontaneous proinflammatory status in depressed elderly patients. Brain Behav Immun 18:135-148.
118. Van Cauter E, Leproult R, Kupfer DJ. 1996. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 81:2468-2473.
119. Vedhara K, Cox N, Wilcock G, Perks P, Lightman S, Shanks N. 1999. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 353: 627-631.
120. Vetta F, Ronzoni S, Lupatelli M, Novi B, Fabbriconi P, Ficconeri C, Cicconetti P, Russo F, Bollea M. 2001. Tumor necrosis factor-alpha and mood disorders in the elderly. Arch Gerontol Geriat Suppl 7:442.
121. Vitaliano PP, Scanlan JM, Zhang J, Savage MV, Hirsch IB, Siegler IC. 2002. A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom Med 64:418-435.
122. Weigent DA, Baxter JB, Wear WE, Smith LR, Bost KL, Blalock JE. 1988. Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J 2:2812-2818.
123. Yin D, Tuthill D, Mufson RA, Shi Y. 2000. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J Exp Med 191:1423-1428.
124. Zhang TY, Ding X, Daynes RA. 2005. The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities. J Immunol 174:879-889.
125. Zipp F, Wendling U, Beyer M, Grieger U, Waiczies S, Wagenknecht B, Haas J, Weller M. 2000. Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells. J Neuroimmunol 110:214-222.
126. Zovato S, Simoncini M, Gottardo C, Pratesi C, Vampollo V, Spigariol A. 1996. Dexamethasone suppression test: corticosteroid receptors regulation in mononuclear leukocytes of young and aged subjects. Aging Clin Exp Res 8:360-364.